EXPRESSION OF THE TUMOR-ASSOCIATED PROTEINS IN THE OVARIAN CANCER

With the help of monoclonal antibodies (MCA-1, MCA-3, G1 class immunoglobulins) and polyspecific antiserum (As) by means of immunoblotting (IB) the increase of the expression of the tumor-associated proteins (TAP) in the samples of the tumor tissues (in 94, 55 and 38% respectively), metastatic lymph...

Full description

Saved in:
Bibliographic Details
Main Authors: T. S. Bobrova, K. I. Zhordania, Yu. V. Chuyev
Format: Article
Language:Russian
Published: ABV-press 2014-09-01
Series:Опухоли женской репродуктивной системы
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/341
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403726443315200
author T. S. Bobrova
K. I. Zhordania
Yu. V. Chuyev
author_facet T. S. Bobrova
K. I. Zhordania
Yu. V. Chuyev
author_sort T. S. Bobrova
collection DOAJ
description With the help of monoclonal antibodies (MCA-1, MCA-3, G1 class immunoglobulins) and polyspecific antiserum (As) by means of immunoblotting (IB) the increase of the expression of the tumor-associated proteins (TAP) in the samples of the tumor tissues (in 94, 55 and 38% respectively), metastatic lymph nodes — LN(m+) and sera of the patients with ovarian cancer (OC) (in 82, 77 and ~100% of the cases, respectively), was detected. The important feature of As was the reactivity with the samples of the LN (m+) on the numerous proteins (>5-10) in 78% of the patients. The statistical analysis of the data using Student t-criterion revealed the significant differences (MCA-1, MCA-3) in the expression of the markers in the tumor tissues and blood sera of the oncological patients compar- ing with the samples of the adjacent tissues, blood sera of the patients with the other tumor localization and healthy donors (p<0,05). The further research using a larger amount of the clinical material and development of the more precise quantitative immunoenzyme analysis to measure TAP, is needed. It is possible that detection of TAP using MCA-1 and As may serve a basis for the creation of the test-system for the immunodiagnostics of the OC and determination of the stage of the tumor process.
format Article
id doaj-art-f5ae6d3a0a4e4f01afe40a07f938dcdf
institution Kabale University
issn 1994-4098
1999-8627
language Russian
publishDate 2014-09-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-f5ae6d3a0a4e4f01afe40a07f938dcdf2025-08-20T03:37:11ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-09-0101657210.17650/1994-4098-2008-0-1-65-72357EXPRESSION OF THE TUMOR-ASSOCIATED PROTEINS IN THE OVARIAN CANCERT. S. Bobrova0K. I. Zhordania1Yu. V. Chuyev2N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowN.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowN.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, MoscowWith the help of monoclonal antibodies (MCA-1, MCA-3, G1 class immunoglobulins) and polyspecific antiserum (As) by means of immunoblotting (IB) the increase of the expression of the tumor-associated proteins (TAP) in the samples of the tumor tissues (in 94, 55 and 38% respectively), metastatic lymph nodes — LN(m+) and sera of the patients with ovarian cancer (OC) (in 82, 77 and ~100% of the cases, respectively), was detected. The important feature of As was the reactivity with the samples of the LN (m+) on the numerous proteins (>5-10) in 78% of the patients. The statistical analysis of the data using Student t-criterion revealed the significant differences (MCA-1, MCA-3) in the expression of the markers in the tumor tissues and blood sera of the oncological patients compar- ing with the samples of the adjacent tissues, blood sera of the patients with the other tumor localization and healthy donors (p<0,05). The further research using a larger amount of the clinical material and development of the more precise quantitative immunoenzyme analysis to measure TAP, is needed. It is possible that detection of TAP using MCA-1 and As may serve a basis for the creation of the test-system for the immunodiagnostics of the OC and determination of the stage of the tumor process.https://ojrs.abvpress.ru/ojrs/article/view/341
spellingShingle T. S. Bobrova
K. I. Zhordania
Yu. V. Chuyev
EXPRESSION OF THE TUMOR-ASSOCIATED PROTEINS IN THE OVARIAN CANCER
Опухоли женской репродуктивной системы
title EXPRESSION OF THE TUMOR-ASSOCIATED PROTEINS IN THE OVARIAN CANCER
title_full EXPRESSION OF THE TUMOR-ASSOCIATED PROTEINS IN THE OVARIAN CANCER
title_fullStr EXPRESSION OF THE TUMOR-ASSOCIATED PROTEINS IN THE OVARIAN CANCER
title_full_unstemmed EXPRESSION OF THE TUMOR-ASSOCIATED PROTEINS IN THE OVARIAN CANCER
title_short EXPRESSION OF THE TUMOR-ASSOCIATED PROTEINS IN THE OVARIAN CANCER
title_sort expression of the tumor associated proteins in the ovarian cancer
url https://ojrs.abvpress.ru/ojrs/article/view/341
work_keys_str_mv AT tsbobrova expressionofthetumorassociatedproteinsintheovariancancer
AT kizhordania expressionofthetumorassociatedproteinsintheovariancancer
AT yuvchuyev expressionofthetumorassociatedproteinsintheovariancancer